Guotai Xu
-
- Cytokine Signaling Pathways and Interactions 1
-
- PI3K/AKT/mTOR signaling in cancer 3
- DNA Repair Mechanisms 2
- Chromatin Remodeling and Cancer 2
- Genomics and Chromatin Dynamics 2
- Sensory Systems top 10%
-
- Advanced Breast Cancer Therapies 1
-
- Ferrocene Chemistry and Applications 1
-
- Cancer Mechanisms and Therapy 1
- Co-authors
- Sven RottenbergLodewyk F.A. WesselsPiet BorstJos JonkersCharlotte GuyaderThijn R. BrummelkampRosa Planells‐CasesFlorian Ullrich
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Communications (1 paper)The EMBO Journal (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Guotai Xu
12 papers receiving 639 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 129
- Oncology 215
- Molecular Biology 482
- Sensory Systems 34
- Physiology 14
Countries citing papers authored by Guotai Xu
This map shows the geographic impact of Guotai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guotai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guotai Xu more than expected).
Fields of papers citing papers by Guotai Xu
This network shows the impact of papers produced by Guotai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guotai Xu. The network helps show where Guotai Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guotai Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2022 | 18 | |
| 3 | 2021 | 18 | |
| 4 | 2021 | 18 | |
| 5 | 2021 | 17 | |
| 6 | 2019 | 50 | |
| 7 | 2019 | 1 | |
| 8 | 2017 | 1 | |
| 9 | 2016 | 115 | |
| 10 | 2015 | 209 | |
| 11 | 2015 | 119 | |
| 12 | 2014 | 53 | |
| 13 | 2013 | 25 |
About Guotai Xu
Guotai Xu is a scholar working on Molecular Biology, Oncology and Cancer Research, having authored 13 papers that have together received 646 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), DNA Repair Mechanisms (2 papers), Chromatin Remodeling and Cancer (2 papers), Genomics and Chromatin Dynamics (2 papers), Cytokine Signaling Pathways and Interactions (1 paper), Advanced Breast Cancer Therapies (1 paper), Ferrocene Chemistry and Applications (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Cancer Research (129 citations), Oncology (215 citations) and Molecular Biology (482 citations). Guotai Xu has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Sven Rottenberg, Lodewyk F.A. Wessels, Piet Borst, Jos Jonkers, Charlotte Guyader, Thijn R. Brummelkamp, Rosa Planells‐Cases, Florian Ullrich, Thomas J. Jentsch and Nora M. Gerhards. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.